PT76595A - PROCESS FOR THE PREPARATION OF BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES - Google Patents

PROCESS FOR THE PREPARATION OF BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES

Info

Publication number
PT76595A
PT76595A PT76595A PT7659583A PT76595A PT 76595 A PT76595 A PT 76595A PT 76595 A PT76595 A PT 76595A PT 7659583 A PT7659583 A PT 7659583A PT 76595 A PT76595 A PT 76595A
Authority
PT
Portugal
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparation
Prior art date
Application number
PT76595A
Other languages
French (fr)
Portuguese (pt)
Other versions
PT76595B (en
Inventor
Charles Malen
Jean-Louis Peglion
Jacques Duhault
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of PT76595A publication Critical patent/PT76595A/en
Publication of PT76595B publication Critical patent/PT76595B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
PT76595A 1982-04-27 1983-04-26 PROCESS FOR THE PREPARATION OF BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES PT76595B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (en) 1982-04-27 1982-04-27 BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLININES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number Publication Date
PT76595A true PT76595A (en) 1983-05-01
PT76595B PT76595B (en) 1986-01-21

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76595A PT76595B (en) 1982-04-27 1983-04-26 PROCESS FOR THE PREPARATION OF BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES

Country Status (22)

Country Link
JP (1) JPS5910584A (en)
KR (1) KR840004428A (en)
AT (1) ATA125383A (en)
AU (1) AU1395383A (en)
BE (1) BE896572A (en)
DD (1) DD209833A5 (en)
DE (1) DE3315106A1 (en)
DK (1) DK183583A (en)
ES (1) ES521895A0 (en)
FR (1) FR2525603A1 (en)
GB (1) GB2133401B (en)
GR (1) GR78481B (en)
IL (1) IL68497A0 (en)
IT (1) IT1167123B (en)
LU (1) LU84770A1 (en)
MA (1) MA19783A1 (en)
NL (1) NL8301476A (en)
NO (1) NO831473L (en)
OA (1) OA07412A (en)
PT (1) PT76595B (en)
SE (1) SE8302347L (en)
ZA (1) ZA832927B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN1805939B (en) 2003-06-17 2010-10-13 艾尼纳制药公司 Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
SI2332921T1 (en) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
EP1838677B1 (en) 2004-12-21 2009-09-09 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
EP2322162A1 (en) 2004-12-23 2011-05-18 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
JP5199997B2 (en) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド Process for preparing 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and related intermediates
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (en) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. Processes for the preparation of 5-ht2c receptor agonists
CA2808904A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
EP2611449A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
EP3485878A1 (en) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
SG188364A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Salts of lorcaserin with optically active acids
RU2674670C1 (en) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Method of correction of body mass

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
NL8301476A (en) 1983-11-16
OA07412A (en) 1984-11-30
PT76595B (en) 1986-01-21
IT8348155A0 (en) 1983-04-26
LU84770A1 (en) 1984-11-28
DD209833A5 (en) 1984-05-23
BE896572A (en) 1983-10-26
GB2133401A (en) 1984-07-25
ATA125383A (en) 1986-05-15
GB2133401B (en) 1985-10-23
SE8302347L (en) 1983-10-28
FR2525603A1 (en) 1983-10-28
MA19783A1 (en) 1983-12-31
IT1167123B (en) 1987-05-13
ES8405796A1 (en) 1984-06-16
JPS5910584A (en) 1984-01-20
IL68497A0 (en) 1983-07-31
GR78481B (en) 1984-09-27
DK183583A (en) 1983-10-28
DK183583D0 (en) 1983-04-26
ES521895A0 (en) 1984-06-16
AU1395383A (en) 1983-11-03
GB8311508D0 (en) 1983-06-02
ZA832927B (en) 1984-06-27
SE8302347D0 (en) 1983-04-26
KR840004428A (en) 1984-10-15
NO831473L (en) 1983-10-28
DE3315106A1 (en) 1983-11-03
FR2525603B1 (en) 1984-09-14

Similar Documents

Publication Publication Date Title
FR2479187B1 (en) PROCESS FOR THE PREPARATION OF N-OCTADIENOL
RO86698A (en) PROCESS FOR THE PREPARATION OF (1-PIPERIDINYLALKYL) -PYRHIMIDINONE
RO81944A (en) PROCESS FOR THE PREPARATION OF IMIDOSULFAMIDES
FR2527615B1 (en) PROCESS FOR THE PREPARATION OF 26,26,26,27,27,27-HEXAFLUORO-1A, 25-DIHYDROXYCHOLESTEROL
PT76595A (en) PROCESS FOR THE PREPARATION OF BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES
RO86511A (en) PROCESS FOR THE PREPARATION OF BETA-LACTAMES
FR2555575B1 (en) PROCESS FOR THE PREPARATION OF 4-ALCOXYANILINES
RO86646A (en) PROCESS FOR THE PREPARATION OF OOMETERS
RO88128A (en) PROCESS FOR THE PREPARATION OF N-PHOSFANOMETILGLICINE
FR2562070B1 (en) PROCESS FOR THE PREPARATION OF 2-AMINO-S-TRIAZINES
FR2496660B1 (en) PROCESS FOR THE PREPARATION OF N-ACYLCARNOSINE
BE889546A (en) PROCESS FOR THE PREPARATION OF N-CYCLOHEXYLBENZOTHIAZOLE-2-SULFENAMIDE
FR2534905B1 (en) PROCESS FOR THE PREPARATION OF PHENYLCETONES
RO88202A (en) PROCESS FOR THE PREPARATION OF SPIRO-3-HETEROAZOLONE
FR2550190B1 (en) PROCESS FOR THE PREPARATION OF B-PHENYLSERINE
PT74559A (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED TRIFLUOROMETHYLPHENYL-TETRAHYDROPYRI-DINES
FR2528825B1 (en) PROCESS FOR THE PREPARATION OF META-CHLOROBENZOTRIFLUORIDE
FR2527603B1 (en) CATALYTIC PROCESS FOR THE PREPARATION OF THIO-BIS-PHENOLS
RO81430A (en) PROCESS FOR THE PREPARATION OF AZOLUL SILIGLYCOLETHERS
FR2529889B1 (en) PROCESS FOR THE PREPARATION OF INDOLES
FR2526021B1 (en) PROCESS FOR THE PREPARATION OF 3-HYDROXY-BENZODIAZEPINONES
FR2550790B1 (en) PROCESS FOR THE PREPARATION OF 4-METHYLIONONE
FR2493310B1 (en) PROCESS FOR THE PREPARATION OF THYMOSINE A1
FR2526790B1 (en) PROCESS FOR THE PREPARATION OF O-PHENYLENEDIAMINE
FR2521556B1 (en) PROCESS FOR THE PREPARATION OF 3, 3'-DIAMINO-DIPHENYLSULFONES